	US 11,925,628 B2
	Applications for nicardipine in preparing anti-lung cancer products
Yongyong Shi, Shanghai (CN); and Zhijian Song, Shanghai (CN)
Assigned to Shanghai Jiao Tong University, Shanghai (CN)
Appl. No. 15/740,776
Filed by SHANGHAI JIAO TONG UNIVERSITY, Shanghai (CN)
PCT Filed Jun. 30, 2015, PCT No. PCT/CN2015/000478 § 371(c)(1), (2) Date Dec. 28, 2017, PCT Pub. No. WO2017/000083, PCT Pub. Date Jan. 5, 2017.
Prior Publication US 2018/0185346 A1, Jul. 5, 2018
Int. Cl. A61P 35/00 (2006.01); A61K 31/4422 (2006.01)

CPC A61K 31/4422 (2013.01) [A61P 35/00 (2018.01)]

2 Claims

1. A method for treating small cell lung cancer or non-small cell lung cancer in a subject comprising administering an effective amount of a pharmaceutical composition consisting essentially of nicardipine as the active ingredient to the subject.